Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toreforant Synovial Biopsy Study in RA
NCT01862224Phase 2Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing JNJ-38518168 with Placebo/JNJ-38518168 (2 arms). Primary endpoint: Assessment of rheumatoid arthritis disease-related biomarkers in synovial biopsy tissue and blood at 52 weeks. Started Jul 2013; status: terminated.
02
Drugs
toreforant
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01862224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01862224.